Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Enanta Pharmaceutica (ENTA)

Enanta Pharmaceutica (ENTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enanta Pharmaceutica 500 ARSENAL STREET WATERTOWN MA 02472 USA

P: 617-607-0800 F: 617-607-0530

Description:

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 1,337,785
Shares Outstanding, K 19,682
Annual Sales, $ 206,630 K
Annual Net Income, $ 71,960 K
Last Quarter Sales, $ 44,370 K
Last Quarter Net Income, $ 7,040 K
60-Month Beta 0.97
% of Insider Shareholders 11.35%
% of Institutional Shareholders 88.79%
Float, K 17,448
% Float 88.65%

Growth:

1-Year Return -23.47%
3-Year Return 173.74%
5-Year Return 72.34%
5-Year Revenue Growth 544.71%
5-Year Earnings Growth 619.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.33 on 08/06/19
Next Earnings Date N/A
Earnings Per Share ttm 3.08
EPS Growth vs. Prev Qtr 65.00%
EPS Growth vs. Prev Year -65.98%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ENTA Ratios

Ratio
Price/Earnings ttm 22.53
Price/Earnings forward 30.08
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 15.16
Return-on-Assets (Before Tax) 14.33
Profit Margin % 34.83
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 6.61
Price/Cash Flow 18.26
Price/Book 3.05
Book Value/Share 22.77
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar